People with HIV Archives – Page 5 of 9

Treatment Action Group Statement on New HIV Remission Case Report at AIDS2020

July 8, 2020
Dorrit Walsh

Yesterday, a widely reported presentation by Ricardo Diaz at the ongoing virtual International AIDS Conference (AIDS2020) disclosed that one out of 30 total participants in an HIV cure-related research trial conducted in Brazil has not experienced an HIV viral load rebound for a little over a year (64.7 weeks) after interrupting antiretroviral therapy (ART).

Webinars

July 6, 2020
Dorrit Walsh

2024 Pre-CROI Community HIV Cure Research Workshop - March 2, 2024 HIV Cure and the Environment: How location informs cure research - Dr. Adam Ward, AVAC, REACH Collaboratory, February 8, 2024 Advancing an HIV Cure – What is Needed? -…

Fair Pricing for Cepheid Xpert Tests (COVID-19, HIV, TB, HCV)

April 3, 2020
Dorrit Walsh

On Friday, April 3, Treatment Action Group (TAG) and Médecins Sans Frontières (MSF), and the Global Coalition of TB Activists (GCTA) held a webinar on the price of Xpert tests for COVID-19, TB, HIV, HCV and other diseases.

Treatment Action Group Statement on HIV Treatments and SARS-CoV-2/COVID-19

March 25, 2020
Dorrit Walsh

Treatment Action Group (TAG) is urging caution regarding the use of antiretroviral (ART) drugs as treatments for SARS-CoV-2/COVID-19. While there is clearly an acute need to carefully and quickly study interventions that may have activity against SARS-CoV-2, the virus which causes COVID-19 disease, it’s vitally important to be aware of the information that is currently available.

Pre-CROI Community HIV Cure Research Workshop 2020

March 7, 2020
Dorrit Walsh

Due to the late cancellation of the in-person Conference on Retroviruses and Opportunistic Infections (CROI), the 2020 Pre-CROI Community HIV Cure Research Workshop took place via Zoom conference on Saturday, March 7th. We thank all presenters, panelists and participants -…

The Future of Biomedical HIV Prevention Trials: Researcher Viewpoints and Community Survey

March 6, 2020
Dorrit Walsh

This report aims to make more accessible to community advocates discussions around ethical conduct of biomedical prevention trials in the era of PrEP. In early 2019, TAG, along with Black AIDS Institute and the HIV Vaccine Trials Network developed an…

Cure-Related Research Resources

February 18, 2020
Chad Cipiti

A resource listing of articles, reports, websites, and ongoing clinical trials related to the research effort to cure HIV infection.

An Activist’s Guide to the LAM Test

February 14, 2020
Chad Cipiti

Tuberculosis (TB) is the number one killer of people living with HIV/AIDS, causing one in three of all AIDS-related deaths. People living with HIV are at increased risk of developing TB, and of dying from it—especially when they have advanced…

Statement from the ACT NOW:END AIDS Coalition on President Trump’s State of the Union Commitment to Eradicate AIDS

February 5, 2020
Dorrit Walsh

The ACT NOW:END AIDS Coalition, of which TAG is a founding member, released this statement today calling for the administration’s efforts to end the HIV epidemic to be rooted in fact, science, and sensible policies that are consistent with the stated goal of ending HIV.

Treatment Action Group Statement on the HVTN 702 HIV Vaccine Trial Results

February 3, 2020
Dorrit Walsh

Treatment Action Group acknowledges with profound disappointment today’s announcement that the HIV Vaccine Trials Network HVTN 702 study did not demonstrate efficacy in preventing HIV acquisition.